Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147

Similar articles for PubMed (Select 1415824)

1.

Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.

Lesser IM, Lydiard RB, Antal E, Rubin RT, Ballenger JC, DuPont R.

Am J Psychiatry. 1992 Nov;149(11):1556-62.

PMID:
1415824
2.

Plasma alprazolam concentrations. Relation to efficacy and side effects in the treatment of panic disorder.

Greenblatt DJ, Harmatz JS, Shader RI.

Arch Gen Psychiatry. 1993 Sep;50(9):715-22.

PMID:
8357297
3.
4.

A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder.

Lydiard RB, Lesser IM, Ballenger JC, Rubin RT, Laraia M, DuPont R.

J Clin Psychopharmacol. 1992 Apr;12(2):96-103.

PMID:
1573046
5.

Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.

Schweizer E, Patterson W, Rickels K, Rosenthal M.

Am J Psychiatry. 1993 Aug;150(8):1210-5.

PMID:
8328566
6.

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.

Schweizer E, Rickels K, Weiss S, Zavodnick S.

Arch Gen Psychiatry. 1993 Jan;50(1):51-60.

PMID:
8422222
7.

The relationship of alprazolam dose to steady-state plasma concentrations.

Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ.

J Clin Psychopharmacol. 1990 Feb;10(1):27-32.

PMID:
2407754
8.

Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.

Carter CS, Fawcett J, Hertzman M, Papp LA, Jones W, Patterson WM, Swinson RP, Weise CC, Maddock RJ, Denahan AQ, et al.

J Clin Psychiatry. 1995 May;56(5):202-10.

PMID:
7737960
9.

Discontinuation reactions to alprazolam in panic disorder.

Pecknold JC.

J Psychiatr Res. 1993;27 Suppl 1:155-70.

PMID:
8145176
10.

Pharmacokinetics and clinical effects of alprazolam following single and multiple oral doses in patients with panic disorder.

Ciraulo DA, Barnhill JG, Boxenbaum HG, Greenblatt DJ, Smith RB.

J Clin Pharmacol. 1986 Apr;26(4):292-8.

PMID:
2871050
11.

Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.

Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, Barnhill J.

Depress Anxiety. 2008;25(8):E18-26.

PMID:
17960759
12.

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.

Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP.

Am J Psychiatry. 1998 Jan;155(1):36-42.

PMID:
9433336
13.

Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.

Pyke RE, Greenberg HS.

J Clin Psychopharmacol. 1989 Feb;9(1):15-21.

PMID:
2651489
14.

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.

Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjödin I, Penttinen JT, Pedersen T, Lehto HJ.

J Clin Psychiatry. 1998 Oct;59(10):528-34.

PMID:
9818634
15.

Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine.

Lepola UM, Rimón RH, Riekkinen PJ.

Int Clin Psychopharmacol. 1993 Summer;8(2):115-8.

PMID:
8345160
16.

Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.

Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, Barnhill J.

J Clin Psychopharmacol. 2006 Oct;26(5):519-23.

PMID:
16974197
17.
18.
19.

Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.

Uhlenhuth EH, Matuzas W, Warner TD, Paine S, Lydiard RB, Pollack MH.

J Clin Psychopharmacol. 2000 Dec;20(6):622-7.

PMID:
11106133
20.

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.

Noyes R Jr, DuPont RL Jr, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD.

Arch Gen Psychiatry. 1988 May;45(5):423-8.

PMID:
3358644
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk